Antibody-drug conjugates (ADCs) took centre stage at the European Society of Medical Oncology (ESMO) Congress in Madrid 20th-24th October, which was back at full capac
The manufacturing of high potent medicines has provided many challenges in terms of safe production, containment and handling due to their toxic nature.
